Trial Profile
Botulinum toxin type A effects on the treatment of keloid lesions; Comparison of intralesional two different doses
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Keloids
- Focus Therapeutic Use
- 14 Dec 2016 New trial record